Advertisement
Advertisement

TOVX

TOVX logo

Theriva Biologics, Inc.

0.35
USD
Sponsored
-0.01
-1.67%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

0.35

0.00
-0.28%

Theriva Biologics, Inc. Profile

About

Theriva Biologics Inc. is a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need. The Company's lead candidate includes VCN-01, SYN-004 and SYN-020. Theriva Biologics Inc., formerly known as Synthetic Biologics Inc., is based in ROCKVILLE, Md.

Info & Links

CEO

Steven A. Shallcross

Headquarters

9605 MEDICAL CENTER DRIVE, SUITE 270
ROCKVILLE, MD 20850, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.therivabio.com

Auditor

BDO USA, P.C

Share holders

52

Employees

16

Theriva Biologics, Inc. Statistics

Valuation Measures

Market Capitalization2

16.20M

Enterprise Value

17.86M

Enterprise Value/EBITDA(ttm)

-0.82

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.56

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-196.84%

Return on Invested Capital(ttm)

-195.60%

Return on Assets(ttm)

-69.28%

Income Statement

Revenue(ttm)

300.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

300.00K

EBITDA(ttm)3

-21.66M

Net Income Available to Common(ttm)

-22.97M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.47

52-Week Change

-44.96%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

45.89M

Dividend Yield

0.00%

Float4

33.51M

% Held by Insiders

0.67%

% Held by Institutions

6.17%

Balance Sheet

Total Cash(mrq)

0.00

Total Cash Per Share(mrq)

0.00

Total Debt(mrq)

1.66M

Total Debt/Equity(mrq)

11.23%

Current Ratio(mrq)

1.74%

Quick Ratio(mrq)

1.74%

Book Value Per Share(mrq)

0.43

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.37

Free Cash Flow(ytd)

-16.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement